News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
266,412 Results
Type
Article (14190)
Company Profile (282)
Press Release (251940)
Section
Business (79501)
Career Advice (153)
Deals (13225)
Drug Delivery (35)
Drug Development (50438)
Employer Resources (31)
FDA (5712)
Job Trends (5127)
News (144380)
Policy (10032)
Tag
2024 BioCapital Digital (6)
2024 BioForest Digital (1)
2024 BioMidwest Digital (4)
2024 Bio NC Digital (4)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (11)
2024 Biotech Beach Digital (5)
2024 Biotech Beach Standard (3)
2024 Genetown Digital (7)
2024 Genetown Standard (7)
2024 Lone Star Bio Digital (4)
2024 Pharm Country Digital (4)
2024 Pharm Country Standard (4)
2025 BioForest Digital (3)
2025 Lone Star Bio Digital (3)
2026 BioMidwest Elite (1)
2026 Biotech Bay Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Pharm Country Elite (1)
Academia (911)
Accelerated approval (2)
Adcomms (12)
Allergies (49)
Alliances (21635)
ALS (60)
Alzheimer's disease (824)
Antibody-drug conjugate (ADC) (86)
Approvals (5727)
Artificial intelligence (107)
Autoimmune disease (10)
Automation (5)
Bankruptcy (104)
Best Places to Work (4560)
BIOSECURE Act (5)
Biosimilars (39)
Biotechnology (232)
Bladder cancer (43)
Brain cancer (19)
Breast cancer (139)
Cancer (1278)
Cardiovascular disease (100)
Career advice (132)
Career pathing (2)
CAR-T (107)
Cell therapy (304)
Cervical cancer (7)
Clinical research (40849)
Collaboration (495)
Compensation (218)
Complete response letters (13)
COVID-19 (1036)
CRISPR (36)
C-suite (141)
Cystic fibrosis (76)
Data (1331)
Denatured (11)
Depression (28)
Diabetes (123)
Diagnostics (1291)
Digital health (3)
Diversity (2)
Diversity, equity & inclusion (9)
Drug discovery (76)
Drug pricing (29)
Drug shortages (3)
Duchenne muscular dystrophy (81)
Earnings (29622)
Editorial (17)
Employer branding (4)
Employer resources (29)
Events (48091)
Executive appointments (396)
FDA (6323)
Featured Employer (32)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (462)
Gene editing (87)
Generative AI (9)
Gene therapy (226)
GLP-1 (354)
Government (1076)
Grass and pollen (2)
Guidances (18)
Healthcare (6586)
Huntington's disease (21)
IgA nephropathy (20)
Immunology and inflammation (78)
Indications (18)
Infectious disease (1098)
Inflammatory bowel disease (110)
Inflation Reduction Act (8)
Influenza (18)
Intellectual property (55)
Interviews (17)
IPO (7261)
IRA (11)
Job creations (860)
Job search strategy (127)
Kidney cancer (6)
Labor market (4)
Layoffs (200)
Leadership (2)
Legal (1386)
Liver cancer (30)
Lung cancer (184)
Lymphoma (81)
Machine learning (1)
Management (7)
Manufacturing (114)
MASH (47)
Medical device (2590)
Medtech (2591)
Mergers & acquisitions (6249)
Metabolic disorders (360)
Multiple sclerosis (51)
NASH (13)
Neurodegenerative disease (57)
Neuropsychiatric disorders (23)
Neuroscience (1187)
NextGen: Class of 2025 (2016)
Non-profit (852)
Northern California (1526)
Now hiring (21)
Obesity (185)
Opinion (100)
Ovarian cancer (59)
Pain (40)
Pancreatic cancer (51)
Parkinson's disease (104)
Partnered (6)
Patents (108)
Patient recruitment (66)
Peanut (35)
People (25488)
Pharmaceutical (48)
Pharmacy benefit managers (5)
Phase I (14421)
Phase II (19006)
Phase III (12013)
Pipeline (678)
Podcasts (46)
Policy (35)
Postmarket research (852)
Preclinical (6058)
Press Release (30)
Prostate cancer (51)
Psychedelics (35)
Radiopharmaceuticals (211)
Rare diseases (270)
Real estate (1414)
Recruiting (12)
Regulatory (8550)
Reports (15)
Research institute (936)
Resumes & cover letters (17)
Rett syndrome (3)
RNA editing (2)
RSV (10)
Schizophrenia (54)
Series A (91)
Series B (59)
Service/supplier (1)
Sickle cell disease (37)
Southern California (1356)
Special edition (11)
Spinal muscular atrophy (117)
Sponsored (11)
Startups (1971)
State (1)
Stomach cancer (4)
Supply chain (18)
The Weekly (33)
United States (11965)
Vaccines (204)
Venture capitalists (28)
Webinars (7)
Weight loss (106)
Women's health (15)
Worklife (2)
Date
Today (74)
Last 7 days (355)
Last 30 days (1610)
Last 365 days (19986)
2025 (4549)
2024 (20556)
2023 (22415)
2022 (26823)
2021 (27805)
2020 (23361)
2019 (16230)
2018 (11741)
2017 (13750)
2016 (11844)
2015 (14352)
2014 (10394)
2013 (7484)
2012 (7532)
2011 (7617)
2010 (7428)
Location
Africa (148)
Alabama (38)
Alaska (2)
Arizona (52)
Arkansas (5)
Asia (17220)
Australia (2915)
California (3477)
Canada (1043)
China (319)
Colorado (134)
Connecticut (143)
Delaware (87)
Europe (37013)
Florida (407)
Georgia (106)
Idaho (16)
Illinois (209)
India (8)
Indiana (85)
Iowa (1)
Japan (68)
Kansas (59)
Kentucky (5)
Louisiana (3)
Maine (11)
Maryland (441)
Massachusetts (2739)
Michigan (69)
Minnesota (134)
Mississippi (1)
Missouri (22)
Montana (14)
Nebraska (4)
Nevada (15)
New Hampshire (14)
New Jersey (870)
New Mexico (12)
New York (949)
North Carolina (516)
North Dakota (4)
Northern California (1526)
Ohio (107)
Oklahoma (9)
Oregon (21)
Pennsylvania (663)
Puerto Rico (3)
Rhode Island (14)
South America (208)
South Carolina (4)
Southern California (1356)
Tennessee (25)
Texas (396)
Utah (48)
Virginia (67)
Washington D.C. (28)
Washington State (316)
Wisconsin (13)
266,412 Results for "hoth therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Hoth Therapeutics Advances Cancer Fighting HT-KIT Program with New Patent Filing and Preclinical Study Initiation
March 27, 2025
·
5 min read
Press Releases
Hoth Therapeutics Regains Compliance with Nasdaq Listing Requirements
January 24, 2025
·
4 min read
Press Releases
Hoth Therapeutics Announces Plans to Submit Expanded Access Application for HT-001 to Support Cancer Patients in Need
March 10, 2025
·
5 min read
Press Releases
Hoth Therapeutics Partners with OnTargetx R&D to Advance Research for Cancer fighting HT-KIT Cancer Therapeutic
February 10, 2025
·
4 min read
Press Releases
Hoth Therapeutics Announces Positive Findings on GDNF’s Potential as a Game-Changer in Obesity Treatment and Reduced Fatty Liver Disease
March 4, 2025
·
7 min read
Press Releases
Hoth Therapeutics Expands Intellectual Property Portfolio with Acquisition of New Patent Applications
January 21, 2025
·
4 min read
Press Releases
Hoth Therapeutics Announces Positive Results for HT-001 in Treating EGFR Inhibitor-Associated Papulopustular Eruptions Findings to be Presented at the American Academy of Dermatology 2025 Annual Meeting
March 5, 2025
·
6 min read
Press Releases
Hoth Therapeutics Announces Positive Preclinical Results for HT-KIT in Aggressive Cancer Gastrointestinal Stromal Tumors (GIST). HT-KIT Triggered Significant Tumor Cell Death as Early as 24 Hours Post-treatment
March 19, 2025
·
6 min read
Press Releases
Hoth Therapeutics Board of Directors Approves Bitcoin as Treasury Reserve Asset
November 20, 2024
·
4 min read
Pharm Country
Hoth Therapeutics to Attend EF Hutton Annual Global Conference, May 15, 2024
Hoth Therapeutics, Inc. is scheduled to attend the EF Hutton Annual Global Conference in New York, NY.
May 1, 2024
·
1 min read
1 of 26,642
Next
